Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
McKesson
Dow
Express Scripts
Moodys

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Surufatinib


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Surufatinib?

Surufatinib is an investigational drug.

There have been 37 clinical trials for Surufatinib. The most recent clinical trial was a Phase 2 trial, which was initiated on December 7th 2015.

The most common disease conditions in clinical trials are Neuroendocrine Tumors, Colorectal Neoplasms, and Carcinoma. The leading clinical trial sponsors are Hutchison Medipharma Limited, Fujian Cancer Hospital, and Sun Yat-sen University.

There are four US patents protecting this investigational drug and thirty-eight international patents.

Recent Clinical Trials for Surufatinib
TitleSponsorPhase
Surufatinib in Patients With Osteosarcoma and Soft Tissue SarcomaSun Yat-sen UniversityPhase 2
Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung CancerSun Yat-sen UniversityPhase 1/Phase 2
Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung CancerLi Zhang, MDPhase 2

See all Surufatinib clinical trials

Clinical Trial Summary for Surufatinib

Top disease conditions for Surufatinib
Top clinical trial sponsors for Surufatinib

See all Surufatinib clinical trials

US Patents for Surufatinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Surufatinib ⤷  Try it Free Stable, concentrated radionuclide complex solutions ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L. (Pozzilli (Isernia), IT) ⤷  Try it Free
Surufatinib ⤷  Try it Free Stable, concentrated radionuclide complex solutions ADVANCED ACCELERATOR APPLICATIONS (ITALY) S.R.L. (Pozzilli (Isernia), IT) ⤷  Try it Free
Surufatinib ⤷  Try it Free Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use Hutchison MediPharma Limited (Shanghai, CN) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
McKesson
Dow
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.